IMOXINE

Details for Australian Trade Mark No. 1001411 (hide)

Owner Idera Pharmaceuticals

Convention US 12 August 2003 78/286.009

Service PETER MAXWELL & ASSOCIATES PO Box R1466 Royal Exchange SYDNEY NSW 1225

IR Number 822788

Various Provisions of paragraph 44(3)(b) applied.

Filing Date 22 January 2004

Classes

Class 5 Pharmaceutical and vaccine adjuvants namely oligonucleotides to enhance the immune system response

Event Publications

15 September 2005 Application Accepted

19 January 2006 Trade Mark Registered/Protected

30 October 2008 Subsequent Owners/Holder Registered - Full Assignment

  Idera Pharmaceuticals is the full asignee of Merck KGaA.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1001412-STELLA A

1001410-AMPLIVAX